Titanium Dioxide.

Riboflavin degrades quickly on exposure to visible and ultraviolet light, and titanium dioxide is the standard opacifier that keeps light out of a capsule shell or coating. The pairing is why riboflavin products are so often opaque rather than clear.

Retinol is photolabile and isomerises under light, so an opaque titanium dioxide coating is used to keep the dosage form dark. The opacifier does nothing biologically, it blocks the light that drives the change.

Cobalamin loses its cyano ligand under light, which is why B12 is handled in amber glass or opaque shells. Titanium dioxide in the shell or film gives that opacity in a solid dose.

Folic acid is broken down by ultraviolet and visible light in solution and in thin films. An opaque titanium dioxide coating keeps the light off it in a tablet or capsule.

Bare titanium dioxide surfaces generate reactive oxygen species under ultraviolet light, so pigment grades are coated with a thin silica layer that quenches that surface activity. Silica in the same formula also serves as the flow aid.

Titanium dioxide scatters and absorbs mostly in the shorter ultraviolet band while zinc oxide extends attenuation into the longer band. Used together the two mineral particles cover a wider stretch of the ultraviolet range than either does alone.

Cholecalciferol degrades on exposure to ultraviolet and visible light. Titanium dioxide scatters light strongly because of its high refractive index, so a coated tablet or an opaque capsule shell reduces what reaches the active. The pairing is a stability decision, not a nutritional one. It is why so many vitamin products carry the opacifier on the label.

Vitamin K1 breaks down under light, a property used deliberately in laboratory work. An opaque shell or coating containing titanium dioxide cuts light transmission to the fill. The opacifier has no metabolic role of its own here. This is formulation practice rather than an ingredient interaction.

Beta-carotene's conjugated double bond chain is what makes it both coloured and vulnerable to light-driven oxidation. Opacified shells reduce that exposure in storage. Titanium dioxide also whitens a formula that the carotenoid would otherwise tint orange, which is a cosmetic rather than a functional reason for its presence. Both reasons appear in real formulas.

Astaxanthin degrades under light and oxygen, which is why it is usually supplied in oil in a soft capsule. Opacifying the shell removes the light variable. The opacifier contributes nothing to absorption or activity. It is a packaging decision expressed as an ingredient.

Lutein and its ester forms photo-oxidise in the same way as other carotenoids. An opaque capsule shell or tablet coat reduces the exposure. As with the other carotenoids, the relationship is protective and physical. No absorption interaction is implied.

Titanium dioxide is a semiconductor photocatalyst: ultraviolet photons promote electrons across its band gap and the resulting charge carriers form hydroxyl radicals and superoxide at the particle surface. Ascorbate is oxidised readily by those species. In a dry, dark, coated tablet this photocatalysis has little opportunity to run; in a translucent or light-exposed system it can. The direction of the interaction is worth naming even when its practical size is small.

The same photocatalytic chemistry that makes titanium dioxide useful for degrading pollutants also oxidises lipophilic antioxidants at the particle surface. Tocopherols are radical scavengers and will be spent doing that job. Coated grades and dark packaging limit the opportunity. Read this as a formulation stability consideration rather than a nutritional one.

A 2026 cell study reports that E171 exposure increased the intracellular labile ferrous iron pool in cultured cells. Labile iron is a redox-active pool distinct from stored or protein-bound iron. This is a laboratory measurement in cells, not a finding about iron status in people taking a supplement. It is listed so the mechanism is on record, not as a dosing instruction.

Calcium carbonate contributes whiteness and bulk to a coating system at low cost, and titanium dioxide contributes opacity per unit weight through its refractive index. Coating formulators combine them to hit a target opacity. Reformulations that reduce titanium dioxide often raise calcium carbonate or rice starch to compensate. This is coating chemistry, not nutrition.

Pigment-grade titanium dioxide is routinely surface treated with amorphous silica and alumina layers. Those layers block charge carriers from reaching the particle surface, which is what reduces photocatalytic degradation of the material around it. The treatment is why pigment grades differ from bare photocatalytic grades of the same crystal. It is a property of the particle surface rather than of titanium dioxide as a formula.

A 2026 animal study reports that food-grade titanium dioxide affected the intestinal mucus barrier by way of gut microbiota changes. Fermentable fibres such as oat beta-glucan feed short-chain fatty acid production that supports normal mucin production. The two therefore act on the same layer from opposite directions in that animal model. This is a laboratory animal finding and does not describe what happens in a person taking a coated tablet.